Concepedia

M. Hellmann

MH

Statistics

Publications

4

Citations

198

H-Index

4

Active since

2012

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

M. Hellmann is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cancer genetics, and pathology.

Top concepts

Publications per year

2012–2021

4

Publications

4

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

Justin F. Gainor, Hira Rizvi, Esther Aguilar et al. · Annals of Oncology · 2020 · 114 citations · Full text

Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature

Bettina M. Knoll, M. Hellmann, Camille N. Kotton · Scandinavian Journal of Infectious Diseases · 2012 · 43 citations

MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB

Kathryn C. Arbour, Ruoxia Shen, Andrew J. Plodkowski et al. · Journal of Thoracic Oncology · 2018 · 30 citations

, , +7

P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status

Biagio Ricciuti, Kathryn C. Arbour, Jingfeng Lin et al. · Journal of Thoracic Oncology · 2021 · 11 citations · Full text

, , +9

1–4 of 4